Mergers & Acquisitions

Windtree Successfully Completes Financial Restructuring Program

Windtree Successfully Completes Financial Restructuring Program -Windtree and Lee’s Pharm Close $10 Million Share Purchase Agreement Giving Lee’s Pharm Controlling Interest in Windtree- – Windtree and Deerfield Restructure and Retire $25 Million Long-term Debt – -Windtree Improves Capital Structure to Support Advancing AEROSURF and KL4 Platform- -Windtree to Host Investor Conference Call Tomorrow November 2, 2017 at 8:00 AM ET- PR Newswire WARRINGTON, Pa. and SHATIN, HONG KONG, Nov. 1, 2017 WARRINGTON, Pa. […]

Stock Analysts

Incyte Tops Q3 Earnings & Sales, Extends AstraZeneca Deal

Incyte Corporation INCY reported strong results for the third quarter of 2017, wherein both earnings and sales topped estimates. Incyte reported earnings of 17 cents per share beating the Zacks Consensus Estimate of 6 cents but lower than the year-ago quarter reported figure of 19 cents. Quarterly revenues were $381.5 million, up 41.6% year over year and beat the Zacks Consensus Estimate of $360.2 million […]

Stock Analysts

Novo Nordisk (NVO) Tops Q3 Earnings Estimates, Lags Sales

Novo Nordisk A/S NVO reported third-quarter 2017 earnings of 63 cents per American Depositary Receipt (ADR) beating the Zacks Consensus Estimate of 58 cents. In fact, the reported figure was ahead of 57 cents earned a year ago. Quarterly revenues were up 1.6% year over year (up 2% in local currency) to $4.2 billion […]

Stock Analysts

KBR Q3 Earnings Beat Estimates, Revenues Miss, Guides Well

Premium technology, engineering, procurement and construction company, KBR, Inc. KBR reported adjusted earnings of 35 cents per share in third-quarter 2017, beating the Zacks Consensus Estimate of 30 cents by 16.7%. Notably, the company’s shares rose an impressive 5.5% at the close of market on Oct 31, following the company’s earnings release. […]